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2.1 ABSTRAK 
Liposarkoma atau barah tisu lemak merupakan salah satu barah yang paling kerap 
dihidapi di kalangan barah tisu lembut, biasanya meliputi 9.8 ke 18%. Badan Kesihatan 
Sedunia (WHO) telah membahagikan liposarkoma kepada beberapa bahagian mengikut jenis 
tisu seperti “well differentiated”, “myxoid”, “pleomorphic” dan “dedifferentiated”. Barah tisu 
lembut didapati kerap merebak ke paru paru, dan kebarangkalian kekerapan merebak ini 
bergantung kepada jenis sub- barah liposarkoma ini. 
 
Penyakit barah tisu yang telah merebak merupakan antara penyebab kematian yang 
paling utama. Oleh itu pengesanan awal barah yang merebak amatlah penting kerana ia 
memberi kesan kepada rawatan serta prognosis pesakit. Saiz barah sebelum ini telah 
dikenalpasti sebagai antara risiko yg penting namun kekurangan data dalam menyokong 
faktor ini disebabkan oleh data yang tidak lengkap serta tepat. Namun, kini telah terdapat 
pelbagai kaedah untuk mengukur saiz barah dengan lebih tepat iaitu dengan teknik pengiraan 
melalui program OsiriX. Di mana program ini mengukur isipadu barah melalui imej CT atau 
MRI yang telah dimuat turun ke program ini. Setelah itu analisa data dilakukan bagi 
mendapatkan kaitan antara isipadu barah dengan “survival” keseluruhan liposarkoma. Selain 
itu, faktor lain yang boleh memberi kesan terhadap barah ini turut dikenalpasti seperti data 
demografik, diagnosis tisu, kawasan pembedahan dan implikasi barah seperti barah merebak 
ke paru paru, kes berulang serta kematian turut disiasat serta dianalisis. 
 
Kajian ini melibatkan sejumlah 38 pesakit yang memenuhi kriteria yang diperlukan, 
dan telah dipilih dari 1 January 2001 hingga 31 Disember 2014. 
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Daripada hasil kajian yang telah dilakukan, terdapat perbezaan antara isipadu barah 
dengan jenis liposarkoma, di mana barah yang lebih agresif mempunyai isipadu barah yang 
lebih kecil. Selain itu, isipadu barah yang besar turut berkait dengan kedalaman diameter 
barah,ketiadaan rawatan kemoterapi serta barah paru paru yang merebak. “Survival” 
keseluruhan liposarkoma dalam kajian ini turut dipengaruhi oleh barah paru paru yang 
merebak. Turut didapati dalam kajian ini, isipadu barah serta faktor lain tidak mempengaruhi 
“survival’ pesakit. 
 
Dengan ini kesimpulan yang dapat diolah daripada kajian ini ialah terdapat kaitan 
yang penting antara isipadu barah dengan kedalaman barah sendiri, ketiadaan rawatan 
kemoterapi serta barah paru paru yang merebak. Survival keseluruhan pesakit di dalam kajian 
ini hanya dipengaruhi oleh barah yang merebak ke paru paru, dan tidak dipengaruhi oleh 
isipadu barah. 
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2.2 ABSTRACT 
Liposarcoma is one of the commonest subtypes of soft tissue sarcoma constituting 
9.8-18 % of cases [1]. The World Health Organization ( WHO) classification of tumors of 
soft tissue and bone 2009 clasiffied liposarcoma into 4 subtypes which were well 
differentiated, myxoid, pleomorphic and dedifferentiated subtypes. Soft tissue sarcomas 
metastasize primarily via hematogenous spread in which they usually settled in pulmonary as 
the main site. Liposarcoma metastasized according to the grade of lesion where high grade 
liposarcoma had the highest metastasis rate which was 50 % (3).  
 
Metastatic disease is the major cause of death in patients with soft tissue 
malignancies. Hence early detection of metastatic disease has important implications for 
prognosis and treatment.   Tumor size was a readily available risk factor but it has been 
neglected in large analyses of prognostic factors largely because of its incompleteness and 
inaccuracy. Tumor volume measurement recently was found to be as accurate and 
reproducible to be used as prognostic indicator.  
 
Therefore we decided to measure the tumor volume via 3- dimensional views from 
CT or MRI and used OsiriX program to interprete the tumor volume. Then we established the 
association of tumor volume with overall survival in liposarcoma. Other than that, we also 
associate other prognostic factors such as demography, histopathological diagnosis, surgical 
margins and the disease outcome for instance pulmonary metastasis, local recurrence and 
death with the surgically treated liposarcoma and its overall survival. 
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This study involved a total of 38 patients which fulfilled the inclusion and exclusion 
criteria, were selected from 1st January 2001 till 31st December 2014. 
 
We found out there were differences with median tumor volume according to 
liposarcoma subtypes, with higher grade tumor presented with smaller tumor volume. Larger 
than median tumor volume was associated in patients with increased depth of tumor, absence 
of adjuvant chemotherapy and presence of pulmonary metastasis. Overall survival in our 
study was significantly influenced by presence of pulmonary metastasis. Tumor volume and 
other prognostic factors were not associated with worsening overall survival. 
 
Therefore we made the conclusion there was significant association between tumor 
volume with increased depth of tumor, absence of adjuvant chemotherapy and presence of 
pulmonary metastasis. Overall survival in this study was associated with presence of 
pulmonary metastasis and was not influenced by the tumor volume. 
 
 
 
 
 
 
 
10 
 
3.0: INTRODUCTION 
  
 Liposarcoma is one of the commonest subtypes of soft tissue sarcoma constituting 
9.8-18 % of cases [1]. The incidence peaks between 40-60 years and there is slight male 
predominance [2]. The World Health Organization Classification of tumors of soft tissue and 
bone 2009 clasiffied liposarcoma into 4 subtypes: well differentiated liposarcoma/ atypical 
lipomatous tumor, myxoid liposarcoma, pleomorphic liposarcoma and dedifferentiated 
liposarcoma.²⁴˒¹² 
 
Liposarcoma commonly metastasize to the lung via hematogenous spread. Metastasis 
disease is the major cause of death and understanding prognostic factors is important for early 
detection and treatment of metastasis disease has important implications for prognosis and 
treatment. Myxoid, pleomorphic and dedifferentiated liposarcoma had been reported to have 
higher incidence of early pulmonary metastases and local recurrence. However other factors 
such as size, depth of tumor, sites and also implicated to final survival of patients. Roger at al 
stated that survival rates is the highest for extremity liposarcoma (93%; 53 months overall 
survival rate) with 11% were contributed by high grade liposarcoma.⁵⁹ This is further 
supported by Robert MC et al in which 2 years and 5 years survival rate for well 
differentiated liposarcoma was 92% and 84% respectively, while for pleomorphic 
liposarcoma which is high grade reported poor survival rate of 70% in 2 years and 50% in 5 
years. The size of tumor does strongly contribute to patient’s prognosis. As stated by 
Kilpatrik et al evaluating prognostic factors in his study of 95 cases with myxoid and round 
cell liposarcoma between 1971 and 1992 showed that the tumor size has an independent 
prognostic impact.⁴⁵ A few other studies done by Reitan JB et al and Orson GS et al reported 
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that larger tumor size is associated with poor survival rate in liposarcoma patients.⁶⁸˒⁶³ 
However, all the studies done were using single dimension to determine the tumor size. 
 
Liposarcoma usually presented with painless asymptomatic growing mass.  Most of 
our patient presented late with huge size of tumor before had surgical treatment. Tumor size 
is one of the negative prognostic factors for liposarcoma survival. However, in large tumor 
the objectivity measurement of size was not definite and accurate. A tumor volume 
measurement method is an accurate and reproducible and more objective in assessments the 
size and used as prognostic indicator. There is numerous ways on how tumor volume was 
calculated in previous studies. Beiling et al. 1996 calculated absolute tumor volume by using 
ellipsoid formula from the three parameters of length, width and depth of the tumor 
determined from two plane X-rays films.⁵ Meanwhile, Shin et al 2000 measured the tumor 
volume by ellipsoid mass formula not only on plain radiography but also on MRI film. 
Furthermore, he also measured the total tumor volume with three dimensional MRI.⁷¹ Until 
now, despite being the commonest soft tissue sarcoma, there has not been any study 
conducted to find association between tumor volume and the occurrence of pulmonary 
metastasis in liposarcoma.  
 
Therefore this study is designed with an objective to look for any association between 
the tumor volume and pulmonary metastasis of liposarcoma especially for high volume tumor 
due to late presentation. 
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4.0: LITERATURE REVIEW 
 
 
 
 
4.1 EPIDEMIOLOGY 
 
 
 Sarcoma is a heterogeneous group of mesenchymal malignancy. It is rare malignancy 
which accounts for 1% of adult tumor and 15% of pediatrics age group tumor ²⁴. 
Approximately 80% of sarcoma arises from soft tissue and 20 % from bone⁸³. In the United 
States, around 8700 new soft tissue sarcoma were diagnosed yearly and 1500 cases annually 
in the UK ⁹. On the other hand, in Asia pacific region, 18000 new cases of sarcoma of bone 
and soft tissue were reported which accounts around 14400 soft tissue sarcoma cases 
expected each year⁸³. There were more than 50 histological subtypes of STS were identified 
with each having unique clinical, prognostic and therapeutic features (WHO). Therefore a 
multidisciplinary approach is mandatory to minimize recurrence, maximize survival and 
preserve functionality and quality of life ⁴⁸. 
 
 Liposarcoma is the second commonest STS after Pleomorphic sarcoma which 
contributes around 20 to 30% of all adult sarcoma²⁴˒⁷˒⁵³.  It is divided in 5 subtypes, with 
well differentiated being the commonest with 40 - 45 % of all tumors²⁴˒¹². Like all other 
malignancies, liposarcoma become more prominent with increasing age with median age of 
56-58 years old⁴²˒²⁸. There is slight male predominance²⁸˒⁵². It is commonly found in the 
lower extremities, as pelvis and thigh region being the predominant sites. These findings 
were supported with what has been reported worldwide⁵³˒²⁴˒⁵⁹. In most literature, the 
retroperitoneum and lower extremities were reported to have high incidence of large tumors. 
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4.2. SUBTYPES OF LIPOSARCOMA 
 
4.2.1 Classification 
 
Liposarcoma can be categorized in 3 biological grade based on molecular and cytogenic 
studies which contain 5 different subtypes based on WHO²⁴˒¹². The low grades which include 
well differentiated subtypes, followed by intermediate grade encompassing of myxoid and 
round cell subtypes. The myxoid type is further classified in 3 groups based on the round cell 
composition. And last but not least are the high grade types which are pleomorphic and 
dedifferentiated liposarcoma. 
 
4.2.2 Age and site of involvement 
 
The common site for liposarcoma is lower extremities with high incidence in thigh followed 
by retroperitoneum ⁶³. Based on WHO, well defferentiated liposarcoma commonly occur in 
deep soft tissue of limbs especially in thigh. It affects the middle aged group with peak 
incidence in 6th decade of life. ²⁴˒¹². As for dedifferentiated liposarcoma, it shares the same 
population aged as WD liposarcoma as dedifferentiation occurs in 10% of WD liposarcoma 
of any subtypes. It tends to occurs in retroperitoneum compare to extremities with the ratio of 
3:1. Furthermore, myxoid liposarcoma usually occurs in deep soft tissue of extremities with 
more than two third from thigh musculature. It is a disease of young adults with peak 
incidence between 4th to 5th decade. Although it is very rare, it is the commonest form of 
liposarcoma in patient younger than 20 years old.  Pleomorphic sarcoma commonly found in 
extremities, particularly the thigh (lower > upper) and rarely affects retroperitoneum and 
trunk, with common occurrence in aged more than 50 years old. ³º. True mixed liposarcoma 
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is extremely rare and predominance in elderly. Most cases are found in intraabdominal and 
retroperitoneum. 
 
4.2.3 Gender 
 
There is no gender predilection in al subtypes of liposarcoma. 
 
4.2.4 Tumor size 
 
Due to painless and slow growing nature of the tumor, liposarcoma can grow into enormous 
size before being diagnosed. The largest size reported in few studies can reach up to 45cm at 
presentation not specific to any subtypes or liposarcoma ⁶³˒⁴⁵. In a study involving myxoid 
and round cell liposarcoma, the cutoff point of tumor is more than 10cm (in greatest 
dimension) is associated with high incidence of metastasis with poor prognosis. The 
significant good prognostic indicator as mentioned by Orson GG in 1987 is tumor size less 
than 15cm, histological grade (WD liposarcoma and low grade myxoid liposarcoma has a 
better prognosis), and surgical stage (no distance metastasis has a good outcome) ⁶³. Reitan et 
al, 1985 concludes that better survival is found in small tumor and this was supported by 
other studies worldwide ⁶⁸. The progression of disease apparently correlates with the size of 
tumor but Gustafson et al, 1985 and Rezsel et al founds no significant correlation between 
size and tendency to metastasis ²⁸˒⁶⁹. They are not much study available which correlate 
individual subtypes of liposarcoma size with occurrence of metastasis. 
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4.2.5 Histopathology of subtypes 
 
4.2.5.1 WELL DIFFERENTIATED (WD) LIPOSARCOMA/ ATYPICAL LIPOMATOUS 
TUMOR (ALT) 
 
ALT/WD liposarcoma is locally aggressive mesenchymal neoplasm. It represents the most 
common subtypes (40-45% reported). Macroscopically, it varies from yellow to white-grey 
with soft, rubbery firm consistency. Histologically, it can be subdivided into 4 types; 
adipocytic, spindle cells, inflammatory and spindle. Generally, WD liposarcoma compose of 
either entirely or partly mature adipocytic proliferation with cell size variation and focal 
nuclear atypia in both adipocytes and stromal cells. In addition to that, the presence of 
scattered stromal cells which is hyperchromatic and often multinucleated with lipoblasts 
which are monovacuolated or multivacuolated lipoblasts may contribute to diagnosis. There 
is no gender preference. 
 
4.2.5.2 DEDIFFERENTIATED LIPOSARCOMA (DDL) 
 
DDL is a malignant adipocytic neoplasm showing transition from ALT/WD liposarcoma to 
non lipogenic sarcoma of variable histological grade either in primary (around 90%) or 
recurrence (10%) group. The transition occurs in up to 10% of WD liposarcoma and the risk 
increases in deep seated lesion. DDL most probably represents a time dependent rather than 
site dependent. Grossly, it appear as large multi nodular yellow masses with solid often tan 
grey non lipomatous (dedifferentiated) area which often show necrosis. Histological hallmark 
is an abrupt transition from WDLPS to non lipogenic sarcoma which usually is high grade. 
There are varieties of histological appearance in dedifferentiation areas. Generally it is 
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divided into undifferentiated pleomorphic sarcoma or intermediate to high grade 
myxofibrosarcoma and low grade dedifferentiation. 
 
4.2.5.3 MYXOID LIPOSARCOMA 
 
ML composed of delicate plexiform capillary network associated with variable numbers of 
lipoblast and primitive mesenchymal like cells with diffuse myxoid stroma. Grossly it 
appears soft, pink tan with mucinous surface. The morphological variant in term of identical 
chromosomes abnormalities of myxoid liposarcoma is round cell liposarcoma. Round cell 
shows histological progression to hypercellular or round cell morphology which associated 
with poorer prognosis. It is manifest as presence of sheets of round blue cells with clear to 
eosinophilic cytoplasm. Strong evidence myxoid and RC liposarcoma represents histological 
continuum of MLS is the present of gradual transition from myxoid to hypercellular/ RC 
areas commonly observed in MLS. 
 
4.2.5.4 PLEOMORPHIC LIPOSARCOMA 
 
PL is a pleomorphic, high grade sarcoma containing variable number of pleomorphic 
lipoblasts with abnormal mitotic figure and area of hemorrhage and necrosis. 
Macroscopically, it presents in pink-tan to brown lesion suggestive of area of hemorrhage and 
necrosis. No areas of ALT or another line of differentiation are evident. Histologically, 
infiltrative margins are present in most cases and varying proportion of pleomorphic 
lipoblasts can be found in all tumors with background of high grade usually pleomorphic 
sarcoma. Focal areas of similar to intermediate to high grade myxofibrosarcoma with 
pleomorphic lipoblasts can be seen in almost half of cases.PL is the rarest subtype of 
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liposarcoma, contributes to 5% of all liposarcomas and 20 % of pleomorphic sarcomas. This 
subtype has a strong predilection to deep soft tissues of proximal extremities especially thigh 
accounts for 30-40% of cases ³º. In the latest study by Mentzel et al and Downes et al 
combined, reported that the vast majority of cases (80%) are deep seated/ or  extra 
compartmental with 20% cases were superficial ⁵⁶˒¹⁴. Local recurrence and metastasis rates 
are 30-50% with overall survival of about 60%. Common site of metastasis is the lung. 
 
4.2.5.5 MIXED LIPOSARCOMA 
 
It is combination of all the subtypes mentioned. Mixed liposarcoma is the rarest types of 
tumor which affects the elder population. Grossly, most cases are large and often 
multinodular with cystic and solid area and grey-yellow cut surface. Microscopically, it is 
visualized as mixed of subtypes of liposarcoma such as present of myxoid area in the 
WDLPS/DDLPS or rare mixed type show combination of myxoid and round cell.  
 
Generally, staging for tumor can be divided into two categories, local and distant staging. 
Local staging comprises of plain X-ray, Computed Tomography (CT) scan and Magnetic 
Resonance Imaging (MRI). On the other hand, distant staging consists of CT scan and radio-
isotope scan depending on part which is commonly involves. Soft tissue sarcoma per se 
spread hematogenously, in particularly the lung. Hence CT scan is mandatory to perform 
provided chest x- ray shows significant abnormalities. 
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4.3 LOCAL STAGING 
 
3.1.1 Plain film Radiography 
 
Plain x- ray has a little role in diagnosing soft tissue tumor as compared to primary bone 
tumor. The well recognized limitation of plain x- ray is lack of contrast resolution. However, 
the limitation should not be underestimated as it can still provide valuable information such 
as detecting matrix calcification, periosteal reaction and cortical destruction in soft tissue 
tumors. Plus it is an easy, cheap and universally available tool ¹³. 
 
3.1.2 CT Scan as local staging. 
 
CT scan has a little value in diagnosing primary soft tissue tumors as compared to bone 
tumors.  
 
3.1.3 MRI as local staging 
 
MR has become the preferred modalities for primary soft tissue tumor evaluation as it 
provides superior soft tissue contrast resolution. Besides, it have provides true multiplanar 
images in axial, sagittal and coronal and devoid of artifacts which commonly appears in CT 
scan⁸¹˒⁸⁷. Plus it has the ability to produce accurate diagnosis by delineating the soft tissue 
extent of the tumor. ⁷⁵ 
 
The intensity of signal varies from low (black) to high (white), depending on chemical 
composition of the soft tissues and the modalities of execution. T1 and T2 weighted image 
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has a different signal intensity depending on the used times. Intravenous administration of 
gadolinum enhances hypervacular lesion and results in high signal intensity in T1 weighted 
images. STIR (Short T1 inversion recovery) supresses fat signal so gadolinum enhanced 
signal intensity are contrasted against black bone marrow or soft tissue fat. 
 
The subtypes of liposarcoma manifest differently in MR images. Few studies have been done 
to evaluate the different subtypes of liposarcoma in MRI. WD liposarcoma has the 
appearance of high SI (signal intensity) lesion on T1 weighted image corresponding to fat 
with fine septae within it, intermediate SI mass iso-intense with adjacent subcutaneous fat in 
T2 weighted images and faint enhancement of lesion post gadolinum suggestive of little 
vascularity. As for myxoid liposarcoma, T1 weighted image shows homogenous mass 
isointense with muscle and homogenous high SI with linear septae in T2 weighted images. 
Post contrast usually shows heterogenous non-enhancing areas which corresponds with 
accumulated mucinous material with no capillary network. Pleomorphic and dedifferentiated 
liposarcoma are aggressive and high grade sarcomas. Haemorrhage and necrosis are usually 
present with high degree of cellular pleomorphism. On T1 and T2 weighted image shows 
heterogenous mass containing low and high SI, indicates area of haemorrhage and necrosis 
with marked heterogenous enhancement post gadolinum which shows rich vascularity of this 
lesion ³˒¹⁵˒¹¹. 
 
In conclusion, MR images play the central role in diagnosis soft tissue tumor. However, the 
baseline imaging should still start with plain radiography and proceed with other imaging 
algorithms if needed. Biopsy is mandatory if malignancy is suspected as histology still 
remains the gold standard for diagnosis ¹³. 
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3.1.4 Comparing CT and MRI as local staging 
 
It has been well established that the MR imaging is more superior to CT scan. This is because 
MRI able to depict tumor boundaries and delineate interface between tumor and surrounding 
soft tissue, generally fat and muscle.⁴ It also can demonstrate the anatomical relationship with 
neurovascular structures better as compared to CT. Besides, the extent of bone marrow 
abnormality can be visualized clearly. ² 
 
Furthermore, the advantage of multiplanar images (coronal, saggital and axial) from MRI 
adds on the superiority in visualizing the tumor from CT scan. CT is superior to MRI in 
showing mineralized tissue such as bone and calcium deposition ¹³. Sundaram M and 
colleagues, 1990 concludes that even though the rim of sclerotic bone not seen in MRI can be 
pictured well in CT but it adds to no additional information to what that already available in 
plain x- rays. ⁷³ 
 
Panicek et al in 1999 concludes that CT and MR imaging are equally accurate in local staging 
of primary soft tissue and bone tumors.⁸⁸ 
 
In general, MR is superior to CT in studying the soft tissues, bone marrow and spine, while 
CT scan in better to study calcified tissues as well as the best imaging modalities for 
pulmonary metastasis. 
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3.2 Distant staging 
 
Soft tissue sarcoma spread via hematogenous, particularly in lung. Nicholas et al, 2005 
reported that pleomorphic and dedifferentiated liposarcoma (high grade) has a high tendency 
to metastasize to lungs as compared to myxoid subtype which favors extra pulmonary 
metastasis.⁵¹ Michelle AG et al, stated high number of pulmonary metastasis in high grade 
subtypes with tumor size more than 5cm but statistically not significant.²⁷ CT is the best 
modalities to detect pulmonary nodules. It has the accuracy of 99.6% in detecting pulmonary 
spread and its sensitivity is greater than plain radiography and traditional tomography. 
Therefore, CT should be done as initial evaluation for patient suspected to have primary soft 
tissue malignancy. However, not to forget chest x- ray as a screening tool for lung metastasis 
with the accuracy of 96.6%.⁷ Extended roles of CT scan apart from distal staging include 
surveillance of pulmonary metastasis and restaging for pulmonary metastasis after 
chemotherapy. 
 
4.4 TUMOUR VOLUME CALCULATION USING OSIRIX 
 
As we know, tumor size is an important and easily obtainable prognostic factor and may 
serve as a risk stratified therapy. Most studies that evaluate size as risk factors only take 
consideration of the largest diameter which traditional measured in one single dimension of 
the primary tumor. However, the best method to determine tumor size is yet to be established. 
Tumor size measurement method should be accurate and reproducible because it is going to 
be used as prognostic factors. There were few studies done previously to evaluate method to 
be used in measurement of size. 
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Tumor volume has been measured using ellipsoid mass formula using plain radiograph and 
MRI or clinically by largest diameter of resected specimens or direct three dimension in MRI 
or CT scan. Somville J et al 2001, studied on reliability of measuring tumor volume by 
different methods for tumors of musculoskeletal systems. He stated that although tumor size 
which is expressed by maximal diameter is an easy and readily available data, but the 
measurement itself shows an error of 5% which relatively considered a large error for a 
simple measurement. Plus, it is difficult to determine the largest diameter in irregular borders. 
He concludes that size is not equivalent to volume and is not reliable as a parameter for 
volume. ⁷² 
 
Study by Beiling P et al 1996 of tumour volume and prognosis in osteosarcoma used tumour 
dimension from plain xrays. He obtained tumor size by using absolute tumor volume (ATV) 
calculated from three parameters of length, depth and width by ellipsoid formula (0.52 x 
ATW X ATL X ATD). The cut off point for ATV of > 150cm3 is associated with high risk of 
pulmonary metastasis.⁵ 
 
The limitation of plain radiography and CT scan is the tendency to underestimate tumor size 
due to inadequacy of soft tissue visualization and poor differentiation between adjacent soft 
tissue and tumor. Hence, MRI is the best modality for defining tumor margin by delineating 
soft tissue components. 
 
Furthermore, measuring tumor volume in soft tissue sarcoma is somewhat different from 
measuring volume of other tissue such as liver, kidney or other organ.²³˒⁶⁴˒¹⁹ Due to the 
nature of tumor with irregular borders, making ellipsoidal method unfit, thus volume maybe 
measured using three dimensional method accurately. 
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Hence, Shin KH et al 2000, reported on the best methods to calculate tumor volume using the 
similar ellipsoidal method as Beiling et al which he applied on radiograph, CT scan and 
MRI.⁷¹˒⁵ He studied three methods of evaluating tumor volume by using volume 
measurement with ellipsoid mass formula by radiograph and MRI and three dimensional 
volume measurement in MRI. He concludes that measurement of tumor volume by three 
dimensional in MRI is more reproducible with sensitivity of 89% and specificity of 73%. 
 
OsiriX is an open source, FDA approved, Digital Imaging Communication Medicine 
(DICOM) software invented by Rosset et al from University of Geneva (2003-2009).⁷º It is a 
highly functional program that allow user to reconstruct and manipulate 3D images and 
coordinate data. The most important preoperative evaluation and surgical planning for disease 
pathology is volume rendering and multiplanar reformatting (MPR).³³ Hence, this program is 
flexible in terms of it does not only cater for radiologist, but clinician too have an easy readily 
access to reconstruct 3D images for further surgical planning.³³˒⁵²˒⁸⁰ 
 
The OsiriX software program was developed as an application for MacOS X. This program 
works by updating the images automatically, followed by processing and manipulation into 
multidimensional image navigation and visualization. ¹³˒²⁶ This program was able to convert 
both 2D and 3D images acquired either from CT or MRI, or even from PET/CT scanners as 
well. The images can be obtained from PACS using a DICOM store function. It can also be 
“pulled” from DICOM query- retrieve function of the program. 
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The accuracy and reliability of OsiriX has been approved by other studies done worldwide. 
For instance, a very precise 3D analysis of cervical spinal canal by reconstructing data from 
MD-CT cervical spine using OsiriX has reported its potential benefits which is equivalent 
values to commercial software and provides reliable 3D information (Tomonari Y et al 
2009).⁷⁷˒⁸⁰˒⁸⁴ Furthermore, G Kim et al,2012  demonstrated less than 0.3mm accuracy and 
high reliability by using OsiriX in his study on kinematics analysis of the knee.⁴¹ This is 
further supported by Fortin M et al, 2012 in his study of paraspinal measurement concludes 
that OsiriX yielded measurements with high intra- rater and inter-software reliability.²⁵ In a 
nutshell, OsiriX is a trustable and accurate software which can be use readily for medical 
imaging. 
 
4.5 STAGING 
 
Staging is a process of interpreting clinical, imaging and histopathologic results in order to 
establish clinical diagnosis and to access the extent of cancer spread. It also aid to determine 
the prognosis and guide treatment options. There are two commonly used staging for 
musculoskeletal tumor which are Enneking Classification and TNM Staging of American 
Joint Committee on Cancer (AJCC) system.²º˒⁸³˒⁸⁵ 
Table 1: The TNM staging of AJCC system is frequently used for soft tissue sarcoma staging. 
